News

Lupin, China’s SUP ink pact for COPD drug Tiotropium DPI
Lupin partners with SUP to commercialize Tiotropium DPI in China, aiming to improve respiratory health with innovative products.
Brits with one of 20 conditions could get up to £749 every month in PIP from DWP
People with one of more than 20 breathing conditions could be eligible for up to £749 a month from the Department for Work ...
Medscape19h
Posttraumatic Stress Disorder May Increase Morbidity Risk in Veterans With HIV
Posttraumatic stress disorder in veterans with HIV increases the risk for AIDS and multiple chronic conditions, especially in ...
Lupin inks agreement with Sino Universal for respiratory product in China
Lupin partners with SUP to commercialize Tiotropium DPI in China for COPD treatment, expanding respiratory care options.
Stockhead21h
Dr Boreham’s Crucible: Sizing up the opportunity for ASX biotech Adherium
Plenty folk have an asthma puffer but few seem to know how to use it. Adherium says its Hailie device is improving compliance ...
Pharmabiz21h
Lupin & Sino Universal Pharmaceuticals ink license and supply agreement for tiotropium DPI in China
Lupin & Sino Universal Pharmaceuticals ink license and supply agreement for tiotropium DPI in China: Our Bureau, Mumbai Monday, June 16, 2025, 14:30 Hrs [IST] Global pharma major ...